Table 5

Effect of absence of staff, HIV testing commodities and PMTCT drugs on monthly MCH consultations in all clinics, post-intervention
N OR P value
Absence of MCH staff
HIV-exposed infants starting follow-up visits 67 0.20 0.200
Any HIV tests in HIV-exposed infants 69 0.06 0.027
Serologic HIV tests in HIV-exposed infants 69 0.10 0.030
Absence of testing supplies
Pregnant women detected as HIV+ 70 0.48 0.166
Any HIV tests in HIV-exposed infants 70 0.90 0.812
Serologic HIV tests in HIV-exposed infants 70 0.56 0.201
Absence of MCH drugs
HIV + pregnant women initiating PMTCT 69 0.56 0.463
HIV + women receiving PMTCT during childbirth 69 0.32 0.196
HIV-exposed infants receiving PMTCT at birth 69 0.32 0.193

Geelhoed et al.

Geelhoed et al. BMC Health Services Research 2013 13:207   doi:10.1186/1472-6963-13-207

Open Data